A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Grooming brand Harry’s picks Team: Changing Minds as winner of its Open Minds Initiative for mental health; brand to provide support, US$5M donation over three years to the program that will leverage video games, sports to train mental health responders

Petros Pharmaceuticals reports positive results from draft label comprehension study of OTC erectile dysfunction drug Stendra avanafil; 30 million men have erectile dysfunction in US, with 25% receiving oral therapy

Merck stops Phase 3 trial of injectable Keytruda, Lynparza combination to treat metastatic castration-resistant prostate cancer; analysis shows drug combo did not show benefit to survival compared with abiraterone acetate or enzalutamide

Osteoporosis often overlooked in men, as only 6% of men tested for disease compared to 12% of women; oral bisphosphonates most prescribed treatment, yet only 54%-to-71% of men continue taking medication after one year: study

FDA approves Novartis’ Pluvicto intravenous lutetium Lu 177 vipivotide tetraxetan to treat progressive, PSMA-positive metastatic castration-resistant prostate cancer; prostate cancer second leading cause of cancer-related deaths in US men

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count